Mental disorders affect 10-20 % of the young population in the world. Major depressive disorder (MDD) is a common mental disease with a multifactorial and not clearly explained pathophysiology. Many cases remain undetected and untreated, which influences patients' physical and mental health and their quality of life also in adulthood. The aim of our pilot study was to assess the prediction value of selected potential biomarkers, including blood cell counts, blood cell ratios, and parameters like peroxiredoxin 1 (PRDX1), tenascin C (TNC) and type IV collagen (COL4) between depressive pediatric patients and healthy peers and to evaluate a short effect of antidepressant treatment. In this study, 27 young depressive patients and 26 non-depressed age-matched controls were included. Blood analyses and immunological assays using commercial kits were performed. Platelet count was the only blood parameter for which the case/control status was statistically significant (p=0.01) in a regression model controlling for the age and gender differences. The results from ELISA analyses showed that the case/control status is a significant predictor of the parameters PRDX1 (p=0.05) and COL4 (p=0.009) in respective regression model considering the age and gender differences between MDD patients and controls. A major finding of this study is that values of platelet count, monocyte to lymphocyte ratio, white blood cell, and monocyte counts were assessed by the Random Forest machine learning algorithm as relevant predictors for discrimination between MDD patients and healthy controls with a power of prediction AUC=0.749.

Department of Pharmacology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovak Republic

Zobrazit více v PubMed

ADIMORA NJ, JONES DP, KEMP ML. A model of redox kinetics implicates the thiol proteome in cellular hydrogen peroxide responses. Antioxid Redox Signal. 2010;13:731–743. doi: 10.1089/ars.2009.2968. PubMed DOI PMC

ALEKSOVSKI B, NECEVA V, VUJOVIC V, MANUSHEVA N, RENDEVSKI V, NOVOTNI A, FILIPCE A, SPASOVSKA A, SOFUJANOVA A, ALEKSOVSKI V, GJORGOSKI I. SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: detection and involved mechanisms. Thromb Res. 2018;165:24–32. doi: 10.1016/j.thromres.2018.03.006. PubMed DOI

AMERICAN PSYCHIATRIC ASSOCIATION (APA) DSM-5. [Accessed January 24, 2020]. https://www.psychiatry.org/psychiatrists/practice/DSMRevised October 2018.

ATAOGLU A, CANAN F. Mean platelet volume in patients with major depression: effect of escitalopram treatment. J Clin Psychopharmacol. 2009;29:368–371. doi: 10.1097/JCP.0b013e3181abdfd7. PubMed DOI

BAHRAMI A, KHORASANCHI Z, SADEGHNIA HR, TAYEFI M, AVAN A, FERNS GA, BAHRAMI-TAGHANAKI H, GHAYOUR-MOBARHAN M. Depression in adolescent girls: relationship to serum vitamins A and E, immune response to heat shock protein 27 and systemic inflammation. J Affect Disord. 2019;252:68–73. doi: 10.1016/j.jad.2019.04.048. PubMed DOI

BERNARAS E, JAUREGUIZAR J, GARAIGORDOBIL M. Child and adolescent depression: A review of theories, evaluation instruments, prevention programs, and treatments. Front Psychol. 2019;10:543. doi: 10.3389/fpsyg.2019.00543. PubMed DOI PMC

BONDADE S, SUPRIYA, SEEMA HS, SHIVAKUMAR BK. Mean platelet volume in depression and anxiety disorder- a hospital based case-control study. Int Neuropsychiatr Dis J. 2018;11:1–8. doi: 10.9734/INDJ/2018/42988. DOI

BOT M, CHAN MK, JANSEN R, LAMERS F, VOGELZANGS N, STEINER J, LEWEKE FM, ROTHERMUNDT M, COOPER J, BAHN S, PENNINX BW. Serum proteomic profiling of major depressive disorder. Transl Psychiatry. 2015;5:e599. doi: 10.1038/tp.2015.88. PubMed DOI PMC

BUSNER J, TARGUM SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007;4:28–37. PubMed PMC

CAI L, XU L, WEI L, CHEN W. Relationship of mean platelet volume to MDD: a retrospective study. Shanghai Arch Psychiatry. 2017;29:21–29. doi: 10.11919/j.issn.1002-0829.216082. PubMed DOI PMC

CANAN F, DIKICI S, KUTLUCAN A, CELBEK G, COSKUN H, GUNGOR A, AYDIN Y, KOCAMAN G. Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study. J Psychiatr Res. 2012;46:298–302. doi: 10.1016/j.jpsychires.2011.11.016. PubMed DOI

CHOMYN A, ATTARDI G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun. 2003;304:519–529. doi: 10.1016/S0006-291X(03)00625-9. PubMed DOI

DINGA R, MARQUAND AF, VELTMAN DJ, BEEKMAN ATF, SCHOEVERS RA, Van HEMERT AM, PENNINX BWJH, SCHMAAL L. Predicting the naturalistic course of depression from a wide range of clinical, psychological, and biological data: a machine learning approach. Transl Psychiatry. 2018;8:241. doi: 10.1038/s41398-018-0289-1. PubMed DOI PMC

FERHAT L, CHEVASSUSAU LOUIS N, JORQUERA I, NIQUET J, KHRESTCHATISKY M, BEN-ARI Y, REPRESA A. Transient increase of tenascin-C in immature hippocampus: astroglial and neuronal expression. J Neurocytol. 1996;25:53–66. doi: 10.1007/BF02284785. PubMed DOI

GAWRYLUK JW, WANG JF, ANDREAZZA AC, SHAO L, YOUNG LT. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol. 2011;14:123–130. doi: 10.1017/S1461145710000805. PubMed DOI

GIALLUISI A, IZZI B, Di CASTELNUOVO A, CHERLETTI C, DONATI MB, De GAETANO G, IACOVIELLO L. Revisiting the link between platelets and depression through genetic epidemiology: new insights from platelet distribution width. Haematologica. 2019;105:e246–e248. doi: 10.3324/haematol.2019.222513. PubMed DOI PMC

GOLLEDGE J, CLANCY P, MAGUIRE J, LINCZ L, KOBLAR S. The role of tenascin C in cardiovascular disease. Cardiovasc Res. 2011;92:19–28. doi: 10.1093/cvr/cvr183. PubMed DOI

KARPATKIN S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood. 1978;51:307–316. doi: 10.1182/blood.V51.2.307.307. PubMed DOI

KNOOPS B, ARGYROPOULOU V, BECKER S, FERTÉ L, KUZNETSOVA O. Multiple roles of peroxiredoxins in inflammation. Mol Cells. 2016;39:60–64. doi: 10.14348/molcells.2016.2341. PubMed DOI PMC

KÖHLER-FORSBERG O, HE W, CHANG Y, ATLAS SJ, MEIGS JB, NIERENBERG AA. White blood cell count at first depression diagnosis as predictor for risk of subsequent hospitalization with depression. Neurol Psych Brain Res. 2017;26:1–6. doi: 10.1016/j.npbr.2017.10.002. DOI

KOUTROUBAKIS IE, PETINAKI E, DIMOULIOS P, VARDAS E, ROUSSOMOUSTAKAKI M, MANIATIS AN, KOUROUMALIS EA. Serum laminin and collagen IV in inflammatory bowel disease. J Clin Pathol. 2003;56:817–820. doi: 10.1136/jcp.56.11.817. PubMed DOI PMC

KRAYTSBERG Y, NEKHAEVA E, BODYAK NB, KHRAPKO K. Mutation and intracellular clonal expansion of mitochondrial genomes: two synergistic components of the aging process? Mech Ageing Dev. 2003;124:49–53. doi: 10.1016/S0047-6374(02)00169-0. PubMed DOI

LEE J, LEE KH, KIM SH, HAN JY, HONG SB, CHO SC, KIM JW, BRENT D. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder. J Affect Disord. 2020;265:325–332. doi: 10.1016/j.jad.2020.01.045. PubMed DOI

MAES M, GALECKI P, CHANG YS, BERK M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:676–692. doi: 10.1016/j.pnpbp.2010.05.004. PubMed DOI

MAZZA MG, TRINGALI AGM, ROSSETTI A, BOTTI RE, CLERICI M. Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders. Gen Hosp Psychiatry. 2019;58:7–12. doi: 10.1016/j.genhosppsych.2019.02.003. PubMed DOI

MINEUR YS, OBAYEMI A, WIGESTRAND MB, FOTE GM, CALARCO CA, LI AM, PICCIOTTO MR. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc Natl Acad Sci USA. 2013;110:3573–3578. doi: 10.1073/pnas.1219731110. PubMed DOI PMC

MOKHTARI-ZAER A, HOSSEINI M, BOSKABADY MH. The effects of exercise on depressive- and anxiety-like behaviors as well as lung and hippocampus oxidative stress in ovalbumin-sensitized juvenile rats. Respir Physiol Neurobiol. 2017;248:55–62. doi: 10.1016/j.resp.2017.12.001. PubMed DOI

MOREL-KOPP MC, McLEAN L, CHEN Q, TOFLER GH, TENNANT C, MADDISON V, WARD CM. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost. 2009;7:573–581. doi: 10.1111/j.1538-7836.2009.03278.x. PubMed DOI

MORIARITY DP, KAUTZ MM, GIOLLABUI NM, KLUGMAN J, COE CL, ELLMAN LM, ABRAMSON LY, ALLOY LB. Bidirectional associations between inflammatory biomarkers and depressive symptoms in adolescents: potential causal relationships. Clin Psychol Sci. 2020;8:690–703. doi: 10.1177/2167702620917458. PubMed DOI PMC

MORRIS G, REICHE EMV, MURRU A, CARVALHO AF, MAES M, BERK M, PURI BK. Multiple immune-inflammatory and oxidative and nitrosative stress pathways explain the frequent presence of depression in multiple sclerosis. Mol Neurobiol. 2018;55:6282–6306. doi: 10.1007/s12035-017-0843-5. PubMed DOI PMC

OGŁODEK EA, JUST MJ, MOŚ DM, JUST K, GRZESIŃSKA A, FRĄSZCZAK M, ARASZKIEWICZ A. Peroxiredoxin-1 (PRDX-1) and peroxiredoxin-3 (PRDX-3) as indicators of sickness behaviour in patients with varying levels of depression severity. Eur Neuropsychopharmacology. 2017;27:S622–S623.

ÖZTÜRK A, SAHAN E, MIRCIK AB, DEVECI E, YILMAZI O, KIRPINAR I. Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment. Arch Clin Psychiatry. 2019;46:9–13. doi: 10.1590/0101-60830000000184. DOI

POLANCZYK GV, SALUM GA, SUGAYA LS, CAYE A, ROHDE LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56:345–365. doi: 10.1111/jcpp.12381. PubMed DOI

PATKI G, SOLANKI N, ATROOZ F, ALLAM F, SALIM S. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res. 2013;1539:73–86. doi: 10.1016/j.brainres.2013.09.033. PubMed DOI PMC

PEIRCE JM, ALVIÑA K. The role of inflammation and the gut microbiome in depression and anxiety. J Neurosci Res. 2019;97:1223–1241. doi: 10.1002/jnr.24476. PubMed DOI

PENG R, DAI W, LI Y. High serum levels of tenascin-C are associated with suicide attempts in depressed patients. Psychiatry Res. 2018;268:60–64. doi: 10.1016/j.psychres.2018.06.069. PubMed DOI

POOLE LB, NELSON KJ. Distribution and features of the six classes of peroxiredoxins. Mol Cells. 2016;39:53–59. doi: 10.14348/molcells.2016.2330. PubMed DOI PMC

RHEE SG. Overview on peroxiredoxin. Mol Cells. 2016;39:1–5. doi: 10.14348/molcells.2016.2368. PubMed DOI PMC

SALIM S. Oxidative stress and the central nervous system. J Pharmacol Exp Ther. 2017;360:201–205. doi: 10.1124/jpet.116.237503. PubMed DOI PMC

SAND JMB, GENOVESE F, GUDMANN NS, KARSDAL MA. Type IV collagen. In: KARSDAL MA, editor. Biochemistry of Collagens, Laminins and Elastin (Second Edition) Academic Press; 2019. pp. 37–49. DOI

SANTOS VN, LEITE-MÓR MM, KONDO M, MARTINS JR, NADER H, LANZONI VP, PARISE ER. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz J Med Biol Res. 2005;38:747–753. doi: 10.1590/S0100-879X2005000500012. PubMed DOI

STUMPER A, MORIARITY DP, COE CL, ELLMAN LM, ABRAMSON LY, ALLOY LB. Pubertal status and age are differentially associated with inflammatory biomarkers in female and male adolescents. J Youth Adolesc. 2020;49:1379–1392. doi: 10.1007/s10964-019-01101-3. PubMed DOI PMC

THOMPSON CB, JAKUBOWSKI JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 1988;72:1–8. doi: 10.1182/blood.V72.1.1.bloodjournal7211. PubMed DOI

TRIFUNOVIC A, WREDENBERG A, FALKENBERG M, SPELBRINK JN, ROVIO AT, BRUDER CE, BOHLOOLY-Y M, GIDLOF S, OLDFORS A, WIBOM R, TORNELL J, JACOBS HT, LARSSON NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429:417–423. doi: 10.1038/nature02517. PubMed DOI

UÇAR HN, ERAY Ş, MURAT D. Simple peripheral markers for inflammation in adolescents with major depressive disorder. Psych Clin Psychopharmacol. 2018;28:254–260. doi: 10.1080/24750573.2018.1423769. DOI

VEIDAL SS, KARSDAL MA, NAWROCKI A, LARSEN MR, DAI Y, ZHENG Q, HAGGLUND P, VAINER B, SKJØT-ARKIL H, LEEMING DJ. Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair. 2011;4:22. doi: 10.1186/1755-1536-4-22. PubMed DOI PMC

WANG X, MICHAELIS EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci. 2010;2:12. doi: 10.3389/fnagi.2010.00012. PubMed DOI PMC

WECKMANN K, DEERY MJ, HOWARD JA, FERET R, ASARA JM, DETHLOFF F, FILIOU MD, IANNACE J, LABERMAIER C, MACCARRONE G, WEBHOFER C, TEPLYTSKA L, LILLEY K, MULLER MB, TURCK CW. Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system. Sci Rep. 2017;7:157–188. doi: 10.1038/s41598-017-16183-x. PubMed DOI PMC

WILLIAMS MS. Platelets and depression in cardiovascular disease: A brief review of the current literature. World J Psychiatry. 2012;2:114–123. doi: 10.5498/wjp.v2.i6.114. PubMed DOI PMC

WHO. 2017. [Accessed March 3, 2020]. https://www.who.int/maternal_child_adolescent/topics/adolescence/mental_health/en/

WHO. [Accessed March 5, 2020]. https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-healthRevised 2019.

ZHOU X, LIU L, LAN X, COHEN D, ZHANG Y, RAVINDRAN AV, YUAN S, ZHENG P, COGHILL D, YANG L, HETRICK SE, JIANG X, BENOLIEL JJ, CIPRIANI A, XIEL P. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. Mol Psychiatry. 2019;24:1478–1488. doi: 10.1038/s41380-018-0047-z. PubMed DOI PMC